Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.

Intranasal vaccination is approved as a booster option in the battle against Covid

As a mix-and-match, or heterologous, booster dosage, the government has added Bharat Biotech’s intranasal vaccine Incovacc to its vaccination programme in response to an increase in cases in other countries, primarily China. As a booster dose, Incovacc is the first intranasal vaccine in the world to be licenced.

In a few days, the vaccination, administered without a needle through the nose, will be accessible at private clinics around the nation. CoWIN, the government’s vaccine management platform, is planned to provide it as an option beginning Friday evening.

After Corbevax in August, this is the second heterologous booster in the vaccine regimen. The country’s top drug regulator approved Incovacc as a primary dose in September and a booster dose in November.

The intranasal vaccine induces an immunological response in the nasal and oral mucosal membranes. According to Hyderabad-based Bharat Biotech, which also manufactures Covaxin, “as an intranasal vaccine, BBV154 may create local antibodies in the upper respiratory tract, which has the potential to minimise infection and transmission.”

Tuesday, as part of its anti-Covid campaign, the government will perform a simulated drill in hospitals nationwide. In addition, beginning on Saturday, two percent of overseas travellers entering the country will be randomly inspected.

In a Friday conference with Health officials, the states were also instructed to increase the proportion of RT-PCR tests from the current 79 per million. In addition, they were instructed to prioritise sewage, pan-respiratory viruses, and facility-based sentinel surveillance. Mansukh Mandaviya, minister of health for India, advised states to raise awareness about Covid-appropriate behaviour, especially in light of impending festivities.


just as a third dosage

Only adults who have had two doses of Covaxin or Covishield will be eligible for a booster dose of Incovacc. For the time being, it will not be delivered to any other group, including those who have already had a booster dose.

This week, the Union Health Secretary requested that all positive samples be sent for genome sequencing to INSACOG network laboratories.

Officials have stated that Incovacc is effective against Omicron variants that reproduce in the upper respiratory system before accessing the lungs.

Previously, the business stated that the vaccine was “safe, well-tolerated, and immunogenic” when compared to its Covaxin in a phase III trial involving over 3,100 participants across 14 sites in India. It has also performed an 875-participant trial to see whether Incovacc may be delivered as a booster to individuals who have received Covaxin or Covishield as their primary vaccine.

According to officials, the vaccine uses a modified chimpanzee adenovirus that cannot reproduce in the body to deliver the Covid spike protein. It was created in collaboration with Washington University-St. Louis by Bharat Biotech. Bharat Biotech was responsible for product development and manufactured while the US university created the spike protein vector and conducted pre-clinical tests.

The addition of Incovacc to the vaccination programme coincides with an increase in Covid cases worldwide. Although the number of cases in the country has continued to fall, with only 153 per day reported for the week ending December 22, there has been an uptick in a number of other nations, including China, South Korea, Japan, the United States, France, Greece, and Italy. During the preceding six weeks, an average of 5.9 million cases were recorded daily on a global level.

A total of 22,2 billion third doses have been delivered in India, with 27 percent of all age groups receiving a booster dose, according to data from the Health Ministry. 40 percent of individuals older than 60 years had health insurance, compared to 22 percent of those between the ages of 18 and 59.

During a high-level review meeting on Thursday, Prime Minister Narendra Modi urged the elderly and weak to receive their third dose.

A senior official stated, “What we have learned over the past few years is that we cannot halt the spread, but we can control it so that the system does not get overloaded.” The rationale for preparing at a time when the number of illnesses in the country is minimal is that we are monitoring situations in other countries.”



Hi, my name is Nisha and I'm an educational journalist based in India. I've always been passionate about the power of education to transform lives, and that's what led me to pursue a career in journalism focused on this area. I completed my Bachelor's degree in English from Hindu College in Delhi in 2013 and then went on to earn my Master's in Journalism and Mass Communication from the Indian Institute of Mass Communication in 2017. During my studies, I also completed several short-term courses on Education in India, Sociology, and other related subjects to deepen my knowledge in this field. I'm particularly interested in improving access to quality education in rural areas, where students often face significant challenges. I've worked on a number of initiatives to address this issue, including advocating for better policies, resources, and practices that can make a difference. As an educational journalist, I'm passionate about using my platform to highlight important issues in the education space. I've covered a wide range of topics, including the impact of technology in the classroom, innovative approaches to teaching and learning, and the challenges facing students from marginalized communities. One of the things I love most about my work is the opportunity to constantly learn and grow. I'm an avid reader and believe that reading is key to expanding one's knowledge and perspective. I'm always seeking out new ideas and insights to help me better understand the world around me. In summary, as an educational journalist, I'm dedicated to using my skills and expertise to make a positive impact in the field of education. I'm committed to improving access to quality education for all students and to using my platform to raise awareness about important issues in this area.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button